10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308 | -26.1% | 7,467 | 0.0% | 0.09% | -59.3% |
| Q2 2023 | $417 | 0.0% | 7,467 | 0.0% | 0.22% | +105.7% |
| Q1 2023 | $417 | -11.3% | 7,467 | -42.1% | 0.10% | +59.1% |
| Q4 2022 | $470 | -99.8% | 12,886 | +118.4% | 0.07% | -8.3% |
| Q2 2022 | $267,000 | -40.5% | 5,901 | 0.0% | 0.07% | -41.0% |
| Q1 2022 | $449,000 | -48.9% | 5,901 | 0.0% | 0.12% | -45.8% |
| Q4 2021 | $879,000 | +2.3% | 5,901 | 0.0% | 0.22% | -55.2% |
| Q3 2021 | $859,000 | -25.7% | 5,901 | 0.0% | 0.50% | +67.9% |
| Q2 2021 | $1,156,000 | +35.2% | 5,901 | +24.9% | 0.30% | +40.4% |
| Q1 2021 | $855,000 | +27.8% | 4,723 | 0.0% | 0.21% | +26.8% |
| Q4 2020 | $669,000 | +70.2% | 4,723 | +50.0% | 0.17% | +48.7% |
| Q3 2020 | $393,000 | – | 3,149 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |